ERIBULIN

Overview

ERIBULIN is a Schedule H drug.
Eribulin is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Eribulin is used to treat breast cancer that has spread to other parts of the body. Eribulin is also used to treat liposarcoma, a rare type of cancer that develops in fatty tissue anywhere in the body. Eribulin is used for liposarcoma that cannot be treated with surgery or has spread throughout the body. Eribulin is usually given after at least 2 other combinations of chemotherapy medications have been tried without successful treatment of symptoms.

Usage

ERIBULIN is generally used to treat: Breast Cancer, Liposarcoma

Frequently Asked Questions

Q: Is it safe on my liver?
A: Check with your Doctor first

Q: Is it safe on my kidney?
A: Check with your Doctor first

Q: Can I take it with alcohol?
A: Not Safe

Q: Is it safe for children?
A: Ask your doctor

Q: Can it be taken during pregnancy?
A: Studies indicate Risk – Doctor advice is must

How Do I Take It?

Route of Administration: IV (Intravenous)

Precautions

Caution should be exercised in patients with history of liver, kidney, heart problems, any allergy, who are taking other medications, during pregnancy and breastfeeding. It may cause dizziness, do not drive a car or operate machinery while taking this medication. It may cause burning, numbness, or tingling in the hands or feet; if it is so consult with your doctor. Avoid contact with people who have infections. Avoid live vaccination during the treatment period. It may reduce platelet counts; avoid injury or bruising. Monitor complete blood cell counts and heart function regularly while taking this medication.

Symptoms of Overdosage

ERIBULIN over-dosage can result in: Difficulty Breathing

Common Side-Effects

ERIBULIN : Black (tar) Colored Stools, Blood Or Red Colored Urine, Body Pain, Chills, Cough, Decreased Urination, Labored Breathing, Fever, Frequent Urination, Head Headache, Increased Thirst, Irregular Heartbeat, Loss Of Appetite, Nasal Congestion, Nausea, Vomit, Pale Skin, Runny Nose, Sneezing, Throat Soreness

Disease Interactions

ERIBULIN can interfere with: Bacterial Infection, Fungal Infection, Neutropenia, Thrombocytopenia, Peripheral Neuropathy, Hypokalemia, Magnesium Deficiency, Heart Arrhythmias, Acute Renal Failure

Technical Classification

ERIBULIN is categorized as: MITOTIC INHIBITORS / ANTINEOPLASTICS

Storage Conditions

Room Temperature (Between 15 To 25 C)

Available Alternatives

What are the other drugs with similar Ingredients?

ERIBULIN

ERIBULIN